Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies

An estimated 1.24 million blood cancer cases occur annually worldwide, accounting for approximately 6% of all cancer cases. Currently, there are no standardized hematology cancer screening tests that are recommended for the general population. CD24 is a mucin-like cell surface molecule and P-selecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapira, Shiran, Kazanov, Dina, Mdah, Fatin, Yaakobi, Hadas, Herishanu, Yair, Perry, Chava, Avivi, Irit, Itchaki, Gilad, Shacham-Abulafia, Adi, Raanani, Pia, Hay-Levy, Mori, Aiger, Gal, Mashiah, Jacob, Lev-Ari, Shahar, Arber, Nadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399145/
https://www.ncbi.nlm.nih.gov/pubmed/34442367
http://dx.doi.org/10.3390/jpm11080724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399145/
https://www.ncbi.nlm.nih.gov/pubmed/34442367
http://dx.doi.org/10.3390/jpm11080724

Ejemplares similares